Pharma Journalist -

Hikma Pharmaceuticals PLC announces that it has signed an agreement with Vectura Group plc (Vectura) for the global development and commercialisation of generic versions of…
Read More...

Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, and Sementis, a biotechnology company developing innovative…
Read More...

Amgen and Provention Bio announced a licensing and co-development agreement for AMG 714, identified by Provention as PRV-015. AMG 714 is a novel anti-IL-15 monoclonal antibody being…
Read More...

Guided Therapeutics announced it has signed an extension of its distribution agreement with its Russian and Eastern European Sales and Marketing partner, Newmars Group Kft. The…
Read More...

Altasciences is excited to announce the completion of their laboratory expansion. The additional space will be dedicated to ligand binding and cell-based assays. Altasciences’…
Read More...

With the event now just 1 week away, I wanted to remind you that there is still time to secure your place at SMi's 4th annual event, Lyophilization USA, taking place on November 15th…
Read More...

Glenmark Pharmaceuticals announced the decision to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings…
Read More...

Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based in South Korea, announced today that the asset transfer deal…
Read More...

Concept Life Sciences announced the expansion of its regulatory GLP (good laboratory practice) capabilities at the Group’s Dundee and Bradford sites. The MHRA has confirmed the…
Read More...

IRX Therapeutics announced that the company’s assets have been acquired by the newly formed Brooklyn ImmunoTherapeutics LLC. This name reflects the company’s focus on advancing the…
Read More...